CareDx, Inc (CDNA)
USD 18.69
(1.41%)
USD 18.69
(1.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -47.97 Million USD | 5.79% |
| 2022 | -50.92 Million USD | 84.62% |
| 2021 | -331.09 Million USD | -179.17% |
| 2020 | -118.6 Million USD | -236.87% |
| 2019 | -35.2 Million USD | 45.37% |
| 2018 | -64.44 Million USD | -475.46% |
| 2017 | 17.16 Million USD | 156.72% |
| 2016 | 6.68 Million USD | 147.3% |
| 2015 | -14.13 Million USD | 43.5% |
| 2014 | -25.01 Million USD | -343.14% |
| 2013 | 10.29 Million USD | 13.16% |
| 2012 | 9.09 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -64.33 Million USD | -6.6% |
| 2024 Q3 | -71.55 Million USD | -1.71% |
| 2024 Q1 | -60.35 Million USD | -25.8% |
| 2023 Q1 | -42.65 Million USD | 16.24% |
| 2023 Q3 | -40.77 Million USD | 20.66% |
| 2023 Q2 | -51.38 Million USD | -20.48% |
| 2023 FY | -47.97 Million USD | 5.79% |
| 2023 Q4 | -47.97 Million USD | -17.67% |
| 2022 Q2 | -147.77 Million USD | 2.43% |
| 2022 Q1 | -151.46 Million USD | 54.25% |
| 2022 FY | -50.92 Million USD | 84.62% |
| 2022 Q4 | -50.92 Million USD | -18.32% |
| 2022 Q3 | -43.03 Million USD | 70.88% |
| 2021 Q4 | -331.09 Million USD | 0.09% |
| 2021 Q2 | -314.47 Million USD | -9.29% |
| 2021 Q3 | -331.38 Million USD | -5.38% |
| 2021 FY | -331.09 Million USD | -179.17% |
| 2021 Q1 | -287.73 Million USD | -142.61% |
| 2020 Q2 | -192.65 Million USD | -1368.6% |
| 2020 FY | -118.6 Million USD | -236.87% |
| 2020 Q4 | -118.6 Million USD | 39.3% |
| 2020 Q1 | -13.11 Million USD | 62.74% |
| 2020 Q3 | -195.38 Million USD | -1.42% |
| 2019 Q2 | -41.43 Million USD | 25.2% |
| 2019 Q4 | -35.2 Million USD | 9.48% |
| 2019 FY | -35.2 Million USD | 45.37% |
| 2019 Q3 | -38.89 Million USD | 6.13% |
| 2019 Q1 | -55.39 Million USD | 14.05% |
| 2018 Q4 | -64.44 Million USD | -409.48% |
| 2018 Q3 | -12.64 Million USD | -356.64% |
| 2018 Q2 | -2.77 Million USD | 67.14% |
| 2018 Q1 | -8.43 Million USD | -149.11% |
| 2018 FY | -64.44 Million USD | -475.46% |
| 2017 FY | 17.16 Million USD | 156.72% |
| 2017 Q4 | 17.16 Million USD | -43.22% |
| 2017 Q3 | 30.22 Million USD | 21.77% |
| 2017 Q2 | 24.82 Million USD | 22.63% |
| 2017 Q1 | 20.24 Million USD | 202.75% |
| 2016 Q3 | 4.13 Million USD | -64.83% |
| 2016 Q4 | 6.68 Million USD | 61.77% |
| 2016 FY | 6.68 Million USD | 147.3% |
| 2016 Q1 | -7.9 Million USD | 44.1% |
| 2016 Q2 | 11.75 Million USD | 248.72% |
| 2015 Q3 | -18.15 Million USD | 14.04% |
| 2015 Q2 | -21.12 Million USD | 9.16% |
| 2015 FY | -14.13 Million USD | 43.5% |
| 2015 Q1 | -23.25 Million USD | 7.05% |
| 2015 Q4 | -14.13 Million USD | 22.16% |
| 2014 Q4 | -25.01 Million USD | 4.94% |
| 2014 Q3 | -26.32 Million USD | -341.47% |
| 2014 Q2 | 10.9 Million USD | 6.06% |
| 2014 Q1 | 10.27 Million USD | -0.13% |
| 2014 FY | -25.01 Million USD | -343.14% |
| 2013 Q1 | 5.86 Million USD | 0.0% |
| 2013 FY | 10.29 Million USD | 13.16% |
| 2013 Q4 | 10.29 Million USD | 0.0% |
| 2012 FY | 9.09 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | -21.606% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | -711.222% |
| Aspira Women's Health Inc. | -331 Thousand USD | -14394.26% |
| Biodesix, Inc. | 34.3 Million USD | 239.843% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | -727.752% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -3759.909% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -3759.909% |
| Bionano Genomics, Inc. | 34.88 Million USD | 237.538% |
| Check-Cap Ltd. | -24.75 Million USD | -93.795% |
| Castle Biosciences, Inc. | -83.53 Million USD | 42.565% |
| DarioHealth Corp. | -7.54 Million USD | -535.612% |
| Exact Sciences Corporation | 1.94 Billion USD | 102.461% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 41.894% |
| Guardant Health, Inc. | 220.22 Million USD | 121.785% |
| ICON Public Limited Company | 3.56 Billion USD | 101.348% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 109.713% |
| Illumina, Inc. | 1.21 Billion USD | 103.952% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | -783.104% |
| iSpecimen Inc. | -2.14 Million USD | -2134.121% |
| Standard BioTools Inc. | 46.5 Million USD | 203.161% |
| MDxHealth SA | 18.88 Million USD | 354.043% |
| 23andMe Holding Co. | -141.37 Million USD | 66.064% |
| Medpace Holdings, Inc. | -103.32 Million USD | 53.569% |
| Myriad Genetics, Inc. | 88.1 Million USD | 154.456% |
| Mainz Biomed B.V. | 349.85 Thousand USD | 13813.11% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | -1866.629% |
| NeoGenomics, Inc. | 269.19 Million USD | 117.822% |
| Neogen Corporation | 735.62 Million USD | 106.522% |
| Inotiv, Inc. | 382.14 Million USD | 112.554% |
| Natera, Inc. | -200.1 Million USD | 76.024% |
| OpGen, Inc. | 11.89 Million USD | 503.435% |
| OPKO Health, Inc. | 230.68 Million USD | 120.797% |
| Psychemedics Corporation | 334 Thousand USD | 14464.072% |
| Prenetics Global Limited | -43.33 Million USD | -10.704% |
| Prenetics Global Limited | -43.33 Million USD | -10.704% |
| Precipio, Inc. | -386 Thousand USD | -12329.016% |
| Personalis, Inc. | -8.02 Million USD | -498.055% |
| RadNet, Inc. | 1.14 Billion USD | 104.177% |
| Sera Prognostics, Inc. | -2.02 Million USD | -2272.7% |
| Sotera Health Company | 2.02 Billion USD | 102.369% |
| Neuronetics, Inc. | 2.79 Million USD | 1815.266% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -212.812% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -212.812% |
| Trinity Biotech plc | 63.73 Million USD | 175.273% |
| T2 Biosystems, Inc. | 33.8 Million USD | 241.903% |
| Twist Bioscience Corporation | -192.4 Million USD | 75.065% |
| Exagen Inc. | -12.77 Million USD | -275.634% |